- Home
- ABUS vs UTL Comparison
ABUS vs UTL Comparison
Compare ABUS & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABUS | UTL |
|---|---|---|
| Founded | 2005 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 888.5M | 899.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ABUS | UTL |
|---|---|---|
| Price | $4.84 | $48.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $5.00 | ★ $55.00 |
| AVG Volume (30 Days) | ★ 1.4M | 133.4K |
| Earning Date | 11-13-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 3.70% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.85 |
| Revenue | $14,606,000.00 | ★ $502,000,000.00 |
| Revenue This Year | $125.30 | $5.98 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | ★ N/A | $17.05 |
| Revenue Growth | ★ 116.64 | 1.03 |
| 52 Week Low | $2.71 | $44.61 |
| 52 Week High | $5.10 | $59.99 |
Technical Indicators
Market Signals| Indicator | ABUS | UTL |
|---|---|---|
| Relative Strength Index (RSI) | 57.71 | 47.85 |
| Support Level | $4.65 | $48.10 |
| Resistance Level | $5.05 | $49.20 |
| Average True Range (ATR) | 0.22 | 0.96 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 67.46 | 37.27 |
Price Performance
Historical ComparisonAbout ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About UTL UNITIL Corporation
Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.